ReNAgade Therapeutics
Signal active
Organization
Contact Information
Overview
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.
About
Industries
Biotechnology, Medical, Therapeutics
Founded
2021
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ReNAgade Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $3.6B in funding across 12 round(s). With a team of 101-250 employees, ReNAgade Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ReNAgade Therapeutics, raised $300.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$300.0M
Details
1
ReNAgade Therapeutics has raised a total of $300.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 300.0M |
Investors
ReNAgade Therapeutics is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Ansbert Gadicke | - | FUNDING ROUND - Ansbert Gadicke | 300.0M |
| MPM Capital | - | FUNDING ROUND - MPM Capital | 300.0M |
| ReNAgade Therapeutics | - | FUNDING ROUND - ReNAgade Therapeutics | 300.0M |
| F2 Ventures | - | FUNDING ROUND - F2 Ventures | 300.0M |
Recent Activity
There is no recent news or activity for this profile.